eMolecules has announced the acquisition of Specs Compound Handling, a provider of chemical compound management services to the life sciences industry.
eMolecules provides a digital chemical search engine, specialising in unique structures with delivery options from a global network of suppliers.
“Welcoming the highly reputable and talented Specs team into eMolecules represents a major milestone and opportunity for our companies and customers,” said Dr Niko Gubernator, CEO and President of eMolecules. “This acquisition accelerates eMolecules vision of delivering world-class capabilities that support the rapid transformation of chemicals into knowledge.”
Dr Johan Tijhuis, CEO of Specs, added: “We are excited to join forces with eMolecules and believe that the combination of our two teams will enhance our value to the drug discovery research community.”
eMolecules’ existing investors, including Avista Capital Partners, supported the transaction.
